Abbott’s Epic Plus Tissue Valves Receives the US FDA’s Approval for the Treatment of Mitral or Aortic Valve Replacement

September 23, 2021 Auto Bot Abbott, approval, FDA, MedTech 0

Shots:

  • The US FDA has approved Abbott’s Epic Plus & Epic Plus Supra Stented Tissue valves to treat patients with aortic or MV disease who undergoes valve replacement surgery. The devices build off Abbott’s Epic surgical valve platform
  • Abbott’s Epic valve including radiopaque markers helps to improve implantation & allows compatibility for future transcatheter valve procedures. The new valves are designed to deliver long-term performance & durability due to Abbott’s anti calcification technology
  • The Epic Plus Mitral holder helps to certify a precise insertion of the valve. The device can be implanted in the aortic or mitral valve position & in patients with complicated anatomies

Click here to­ read full press release/ article | Ref: Abbott | Image: The Street

The post Abbott’s Epic Plus Tissue Valves Receives the US FDA’s Approval for the Treatment of Mitral or Aortic Valve Replacement first appeared on PharmaShots.